Literature DB >> 17585052

Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas.

Christina Spaulding1, Erica J Reschly, Derek E Zagort, Yumi Yashiro-Ohtani, Levi J Beverly, Anthony Capobianco, Warren S Pear, Barbara L Kee.   

Abstract

Oncogenic Notch1 mutations are found in most T-lineage acute lymphoblastic leukemias in humans and T-cell lymphomas in mice. However, the mechanism by which Notch1 promotes transformation or maintains malignant cell survival has not been determined fully. Here, we report that expression of the transcription factor lymphoid enhancer factor 1 (Lef1) is Notch dependent in murine T-cell lymphomas in vitro and in vivo, and that the intracellular domain of Notch1 (ICN1) is present at the Lef1 promoter. Lef1 expression is not Notch dependent in primary T-cell progenitors, but Lef1 mRNA is increased by ectopic expression of ICN1 in these cells. We show that Lef1 is required for survival of T-cell lymphoma lines, and that ectopic expression of Lef1 delays lymphoma cell death in the absence of Notch signaling, indicating that Lef1 is an important Notch target in these cells. Therefore, Notch1 co-opts Lef1 during the process of transformation to maintain survival of T-cell lymphomas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17585052     DOI: 10.1182/blood-2007-04-084202

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis.

Authors:  Albert Gutierrez; Renee C Tschumper; Xiaosheng Wu; Tait D Shanafelt; Jeanette Eckel-Passow; Paul M Huddleston; Susan L Slager; Neil E Kay; Diane F Jelinek
Journal:  Blood       Date:  2010-07-01       Impact factor: 22.113

2.  Luteinizing hormone receptor deficiency increases the susceptibility to alkylating agent-induced lymphomagenesis in mice.

Authors:  Yinghao Yu; Fangping Yuan; Xian Li; Dexin Lin; Zijian Lan; C V Rao; Zhenmin Lei
Journal:  Horm Cancer       Date:  2010-10       Impact factor: 3.869

3.  Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.

Authors:  Elena Cubedo; Andrew J Gentles; Chuanxin Huang; Yasodha Natkunam; Shruti Bhatt; Xiaoqing Lu; Xiaoyu Jiang; Isabel Romero-Camarero; Aharon Freud; Shuchun Zhao; Carlos E Bacchi; Jose A Martínez-Climent; Isidro Sánchez-García; Ari Melnick; Izidore S Lossos
Journal:  Blood       Date:  2012-04-19       Impact factor: 22.113

4.  Repression of Ccr9 transcription in mouse T lymphocyte progenitors by the Notch signaling pathway.

Authors:  Veena Krishnamoorthy; Tiffany Carr; Renee F de Pooter; Akinola Olumide Emanuelle; Emanuelle Olumide Akinola; Fotini Gounari; Barbara L Kee
Journal:  J Immunol       Date:  2015-02-20       Impact factor: 5.422

5.  Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development.

Authors:  Qing Wang; Ran Yan; Nancy Pinnell; Anna C McCarter; Yeonjoo Oh; Yiran Liu; Cher Sha; Noah F Garber; Yitong Chen; Qingqing Wu; Chia-Jui Ku; Ivy Tran; Amparo Serna Alarcon; Rork Kuick; James Douglas Engel; Ivan Maillard; Tomasz Cierpicki; Mark Y Chiang
Journal:  Blood       Date:  2018-08-03       Impact factor: 22.113

6.  Ring Finger Protein 14 is a new regulator of TCF/β-catenin-mediated transcription and colon cancer cell survival.

Authors:  Beibei Wu; Sarah Piloto; Weihua Zeng; Nate P Hoverter; Thomas F Schilling; Marian L Waterman
Journal:  EMBO Rep       Date:  2013-03-01       Impact factor: 8.807

7.  The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy.

Authors:  Shuyang Yu; Xinyuan Zhou; Farrah C Steinke; Chengyu Liu; Shann-Ching Chen; Oksana Zagorodna; Xuefang Jing; Yoshifumi Yokota; David K Meyerholz; Charles G Mullighan; C Michael Knudson; Dong-Mei Zhao; Hai-Hui Xue
Journal:  Immunity       Date:  2012-10-25       Impact factor: 31.745

Review 8.  Paradoxical role of Id proteins in regulating tumorigenic potential of lymphoid cells.

Authors:  Sumedha Roy; Yuan Zhuang
Journal:  Front Med       Date:  2018-07-24       Impact factor: 4.592

9.  Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.

Authors:  Ila Joshi; Lisa M Minter; Janice Telfer; Renée M Demarest; Anthony J Capobianco; Jon C Aster; Piotr Sicinski; Abdul Fauq; Todd E Golde; Barbara A Osborne
Journal:  Blood       Date:  2008-11-10       Impact factor: 22.113

10.  Attracting AID to targets of somatic hypermutation.

Authors:  Atsushi Tanaka; Hong Ming Shen; Sarayu Ratnam; Prashant Kodgire; Ursula Storb
Journal:  J Exp Med       Date:  2010-01-25       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.